| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | STE Steris Plc | Tamaro Renato | V.p. &Corporate Treasurer | Sell | 5,036 | $257.55 | $1,297,039.68 | -19.9% | -4.5% | - | |
| Nov 18, 2025 | IRIX Iridex Corp | Dizon Romeo R58 | Chief Financial Officer | Buy | 2,133 | $0.94 | $2,005.02 | +2.7% | +42.4% | - | |
| Nov 18, 2025 | GKOS Glaukos Corp | Gilliam Joseph E55 | President &COO | Sell | 19,340 | $90.00 | $1,740,600.00 | -17.3% | +16.4% | - | |
| Nov 18, 2025 | MMSI Merit Medical Systems Inc | Lampropoulos Fred P.64 | Executive Chairman | Sell | 5,000 | $84.83 | $424,130.00 | -0.5% | -3.1% | - | |
| Nov 18, 2025 | SRTS Sensus Healthcare, Inc. | Sardano Joseph C81 | Chief Executive Officer | Buy | 25,000 | $4.03 | $100,750.00 | +2.1% | -5.2% | - | |
| Nov 18, 2025 | AVNS Avanos Medical, Inc. | Holbrook Kerr | SVP, Chief Commercial Officer | Sell | 15,000 | $11.00 | $165,014.21 | -4.2% | +32.7% | - | |
| Nov 18, 2025 | AORT Artivion, Inc. | Hoff Elizabeth A | Director | Sell | 4,200 | $45.10 | $189,411.60 | -13.4% | -18.6% | - | |
| Nov 18, 2025 | SSKN Strata Skin Sciences, Inc. | Rubinstein Samuel45 | Director | Buy | 5,000 | $1.41 | $7,028.32 | +51.5% | -77.1% | - | |
| Nov 18, 2025 | SIBN Si-Bone, Inc. | Francis Laura70 | Chief Executive Officer | Sell | 16,752 | $17.51 | $293,385.15 | -0.8% | -16.9% | - | |
| Nov 17, 2025 | SIBN Si-Bone, Inc. | Maheshwari Anshul67 | Chief Financial Officer | Sell | 3,460 | $17.43 | $60,297.12 | -0.8% | -14.9% | - | |
| Nov 17, 2025 | SMLR Semler Scientific, Inc. | Murphy-Chutorian Douglas84 | CEO, Interim CFO And Director | Sell | 70,406 | $20.21 | $1,422,608.22 | -36.6% | - | - | |
| Nov 17, 2025 | INCY Incyte Corp | Denton Sheila A. | EVP &General Counsel | Sell | 278 | $104.36 | $29,012.08 | -1.0% | -2.9% | - | |
| Nov 17, 2025 | TMDX Transmedics Group, Inc. | Hassanein Waleed H56 | President &CEO | Buy | 8,775 | $114.00 | $1,000,350.00 | +1.8% | +18.0% | - | |
| Nov 17, 2025 | SSKN Strata Skin Sciences, Inc. | Rubinstein Samuel45 | Director | Sell | 14,094 | $1.33 | $18,803.84 | -39.8% | -78.3% | - | |
| Nov 17, 2025 | SGHT Sight Sciences, Inc. | Taylor Brenton74 | EVP, Operations &R&D | Sell | 14,418 | $7.06 | $101,791.08 | -7.8% | -23.9% | - | |
| Nov 17, 2025 | OM Outset Medical, Inc. | Trigg Leslie84 | Chair And CEO | Sell | 916 | $4.60 | $4,213.60 | -0.7% | -33.9% | - | |
| Nov 17, 2025 | ELUT Elutia Inc. | Colpman David | Director | Buy | 15,500 | $0.74 | $11,470.00 | +500.3% | +57.5% | - | |
| Nov 17, 2025 | SIBN Si-Bone, Inc. | Recupero Anthony J63 | President, Commercial Ops | Sell | 3,833 | $17.44 | $66,832.02 | -0.7% | -14.9% | - | |
| Nov 17, 2025 | SIBN Si-Bone, Inc. | Pisetsky Michael A.68 | SVP, Ops &Adm/ Chief Legal Ofr | Sell | 3,328 | $17.41 | $57,933.66 | -0.7% | -14.9% | - | |
| Nov 17, 2025 | OM Outset Medical, Inc. | Nash Marc83 | EVP Operations R&D &Service | Sell | 247 | $4.60 | $1,136.20 | -0.5% | -33.9% | - | |
| Nov 17, 2025 | IRIX Iridex Corp | Dizon Romeo R58 | Chief Financial Officer | Buy | 3,124 | $0.96 | $2,998.76 | +2.0% | +40.6% | - | |
| Nov 17, 2025 | AORT Artivion, Inc. | Horton Amy48 | VP, Chief Accounting Officer | Sell | 6,000 | $45.73 | $274,380.00 | -4.2% | -19.1% | - | |
| Nov 17, 2025 | AVTR Avantor, Inc. | Ligner Emmanuel | President And CEO | Buy | 87,500 | $11.35 | $993,125.00 | +44.7% | -16.8% | - | |
| Nov 17, 2025 | TELA Tela Bio, Inc. | Ew Healthcare Partners Fund 2, L.P.57 | - | Buy | 3,604,000 | $1.11 | $4,000,440.00 | +87.7% | -32.8% | - | |
| Nov 17, 2025 | OM Outset Medical, Inc. | Brottem John L.84 | General Counsel | Sell | 388 | $4.60 | $1,784.80 | -0.8% | -33.9% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.